C/P | Sector | | Status | Deal Name | Parent | Leads | Region | Date |
|
---|
ABS | ESOT | | | DRUG 2012-1 (USD 195m) | DRI Capital Inc | | USOA | Mar 21, 2012 | | Class | CCY | SIZE (M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | IPT | GDNC | SPRD | CPN | YLD | PRICE |
---|
Y1 | UJE | 47.500 | 3.30 | Qrr2 | EEE | - | - | - | - | - | Rxpejllp | - | - | - | - | 3sD+325 | - | - | R2 | PBI | 72.400 | 4.50 | Gtt2 | BBB | - | - | - | - | - | Rjcckocf | Zbbbw | - | - | - | - | 5.850% | - |
Tranche Comments Y1: Registration: Wzqyed;
R2: Registration: Czmtxq; |
|